The standard of care for stage III NSCLC in the era of immunotherapy: An Italian national survey on the current pattern of care among Italian thoracic oncologists
Alessio Bruni(University of Modena and Reggio Emilia), Vieri Scotti(University of Florence), Venerino Poletti(University of Bologna), Fassina Katia(Azienda Ospedaliero-Universitaria Careggi), Rita Chiari(Azienda Ospedaliera di Perugia), Maria Taraborrelli(Ospedale SS. Annunziata), Paolo Borghetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Stefano Vagge(Ospedale Policlinico San Martino), Emilio Bria(Università Cattolica del Sacro Cuore), Francesco Grossi(University of Insubria), Giuseppe Luigi Banna(Ospedale Cannizzaro), Enrica Capelletto(University of Turin), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Marcello Tiseo(University of Parma), Massimiliano Paci(Azienda Sanitaria Unità Locale di Reggio Emilia), L Buffoni(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Serena Badellino, Elizabeth H. Baldini(Dana-Farber Cancer Institute), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 1
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|454